Literature DB >> 11937878

Comparison of biochemical markers of bone metabolism in serum and femur aspirates.

Christian E Berger1, Andreas Kröner, Eva Thomas, Karl-Heinz Kristen, Emil Ogris, Alfred Engel.   

Abstract

In 27 patients undergoing arthroscopy of the knee for treatment of meniscal diseases, biochemical markers of bone metabolism were measured in cancellous bone, and levels were compared with concentrations obtained from peripheral blood. Bone-specific alkaline phosphatase, osteocalcin, and collagen Type I metabolites (procollagen Type I N-terminal peptide and carboxy-terminal cross-linked telopeptide) were studied simultaneously in serum and in the distal femur using a radioimmunoassay. Although levels of bone-specific alkaline phosphatase and osteocalcin did not differ between serum and cancellous bone, concentrations of collagen Type I metabolites were elevated significantly in healthy cancellous bone. The close correlations between bone and serum concentrations confirmed accuracy of results obtained from cancellous bone. The mean bone-to-serum ratio for alkaline phosphatase and osteocalcin was 1.1 and 1.2, respectively. Collagen Type I metabolite ratios of 2.2 (for carboxy-terminal cross-linked telopeptide) and 2.3 (for procollagen Type I N-terminal peptide) indicate that these markers are formed locally and then released into the circulation. Bone seems to be a major contributor of collagen Type I metabolites to the serum pool.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11937878     DOI: 10.1097/00003086-200202000-00019

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  2 in total

1.  Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip.

Authors:  Christian E Berger; Andreas Kröner; Helmar Stiegler; Thomas Leitha; Alfred Engel
Journal:  Int Orthop       Date:  2004-12-30       Impact factor: 3.075

2.  IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women.

Authors:  Jian-min Liu; Hong-yan Zhao; Guang Ning; Ying Chen; Lian-zhen Zhang; Li-hao Sun; Yong-ju Zhao; Man-yin Xu; Jia-lun Chen
Journal:  J Bone Miner Metab       Date:  2008-02-27       Impact factor: 2.626

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.